![Frontiers | Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model Frontiers | Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model](https://www.frontiersin.org/files/Articles/641447/fimmu-12-641447-HTML/image_m/fimmu-12-641447-g001.jpg)
Frontiers | Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model
![Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2 | ACS Infectious Diseases Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2 | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.1c00486/asset/images/medium/id1c00486_0002.gif)
Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2 | ACS Infectious Diseases
![Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy: Molecular Therapy Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy: Molecular Therapy](https://www.cell.com/cms/asset/7560a09b-9f15-49d3-8070-5067ba6d4ad4/fx1.jpg)